Top Pediatric Neurology Device Companies

Pediatric Neurology Device Market size was valued at USD 3.96 Billion in 2024 and is poised to grow from USD 4.23 Billion in 2025 to USD 7.21 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033).

The global paediatric neurology device market is still in its nascent phase and has a lot of room to grow, which is why many new companies are entering the market with innovative neurology devices for children. Product innovation is predicted to be a crucial strategy that new as well as established paediatric neurology device manufacturers should focus on if they wish to make a mark in the global landscape. Paediatric neurology device companies can also partner and collaborate with healthcare institutions and research institutions to expand their business potential and reach. Market players can also leverage neurology awareness programs launched by governments and public health organisations to market their products. Established paediatric neurology device companies are investing heavily in the research and development of novel devices to expand their product portfolio and stand out from the competition. 'Medtronic plc (Ireland)', 'Abbott Laboratories (USA) ', 'Boston Scientific Corporation (USA) ', 'Johnson & Johnson (USA) ', 'LivaNova PLC (UK) ', 'Integra LifeSciences (USA) ', 'Natus Medical Incorporated (USA) ', 'Nihon Kohden Corporation (Japan) ', 'B. Braun Melsungen AG (Germany) ', 'Stryker Corporation (USA) ', 'Siemens Healthineers AG (Germany) ', 'Philips Healthcare (Netherlands) ', 'Computational Diagnostics, Inc. (USA) ', 'Elekta AB (Sweden) ', 'NeuroPace, Inc. (USA) ', 'Terumo Corporation (Japan) ', 'Smith+Nephew (UK) ', 'Mizuho OSI (USA) ', 'Orpyx Medical Technologies Inc. (Canada) ', 'Magstim (UK)'

Awareness regarding neurological diseases among people of all age groups has been increasing rapidly owing to the high prevalence of neurological disorders and the launch of different awareness initiatives about the same on a global level. Increasing mortality rates of people affected by neurological disorders are also boosting paediatric neurology device sales.

Better Neurological Disease Diagnosis: Diagnosing neurological illnesses has been a challenge for quite a while but with advancements in healthcare technology and neurology research, this challenge has now turned into a huge opportunity for paediatric neurology device suppliers. Paediatric neurology device manufacturers are focusing on the integration of advanced technologies to improve the diagnostic accuracy of their products. Artificial intelligence, advanced medical imaging, and machine learning are some key technologies that companies can integrate to improve their device performance.

The surging prevalence of neurological disorders is the prime factor making North America an unmissable regional market in the world. The presence of robust healthcare infrastructure, high healthcare spending potential, better availability of advanced neurology treatments, and high spending on neurology research are other factors that make this region a highly lucrative one for paediatric neurology device suppliers. The United States is estimated to emerge as the top spot for paediatric neurology device companies operating in the North American region going forward. Government support for neurology research programs is fostering innovation and leading to the development of advanced paediatric neurology devices in this region.